This site is intended for healthcare professionals

Madrigal Pharmaceuticals announces three abstracts to be presented at The Liver Meeting Digital Experience in November 2020, including phase III MAESTRO-NAFLD-1 trial.

Read time: 2 mins
Last updated:16th Mar 2021
Published:8th Oct 2020
Condition: Non Alcoholic Steatohepatitis (NASH)
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest